Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Working Capital to Net Assets Ratio
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Working Capital to Net Assets ratio of 51.8% as of March 2026. Working capital of CN¥4.52 Billion (current assets of CN¥5.74 Billion minus current liabilities of CN¥1.22 Billion) is measured against net assets of CN¥8.72 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Tianjin Chase Sun Pharmaceutical Co Ltd (300026) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tianjin Chase Sun Pharmaceutical Co Ltd Working Capital to Net Assets (2006–2024)
This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2006 to 2024. As of March 2026, the ratio stands at 51.8%, reflecting working capital of CN¥4.52 Billion against net assets of CN¥8.72 Billion CNY. For the complete balance sheet picture, see 300026 asset base.
Annual Working Capital to Net Assets for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 300026 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 51.5% | CN¥4.53 Billion | CN¥8.80 Billion | CN¥6.15 Billion | CN¥1.62 Billion | ▼ -6.7 pp |
| 2023 | 58.1% | CN¥5.16 Billion | CN¥8.87 Billion | CN¥6.72 Billion | CN¥1.56 Billion | ▲ +2.5 pp |
| 2022 | 55.6% | CN¥4.71 Billion | CN¥8.46 Billion | CN¥7.39 Billion | CN¥2.68 Billion | ▼ -4.1 pp |
| 2021 | 59.7% | CN¥4.75 Billion | CN¥7.95 Billion | CN¥6.81 Billion | CN¥2.06 Billion | ▲ +14.1 pp |
| 2020 | 45.6% | CN¥3.37 Billion | CN¥7.39 Billion | CN¥5.71 Billion | CN¥2.34 Billion | ▲ +1.9 pp |
| 2019 | 43.8% | CN¥3.09 Billion | CN¥7.07 Billion | CN¥4.33 Billion | CN¥1.23 Billion | ▼ -3.0 pp |
| 2018 | 46.8% | CN¥3.08 Billion | CN¥6.58 Billion | CN¥3.91 Billion | CN¥836.85 Million | ▲ +1.7 pp |
| 2017 | 45.1% | CN¥2.93 Billion | CN¥6.51 Billion | CN¥3.81 Billion | CN¥874.78 Million | ▲ +0.4 pp |
| 2016 | 44.7% | CN¥2.70 Billion | CN¥6.04 Billion | CN¥3.90 Billion | CN¥1.20 Billion | ▼ -2.6 pp |
| 2015 | 47.2% | CN¥2.50 Billion | CN¥5.29 Billion | CN¥3.64 Billion | CN¥1.14 Billion | ▼ -8.7 pp |
| 2014 | 56.0% | CN¥1.32 Billion | CN¥2.36 Billion | CN¥1.98 Billion | CN¥660.65 Million | ▲ +7.0 pp |
| 2013 | 49.0% | CN¥834.02 Million | CN¥1.70 Billion | CN¥1.31 Billion | CN¥474.81 Million | ▲ +2.7 pp |
| 2012 | 46.3% | CN¥641.98 Million | CN¥1.39 Billion | CN¥980.05 Million | CN¥338.07 Million | ▼ -8.8 pp |
| 2011 | 55.0% | CN¥578.01 Million | CN¥1.05 Billion | CN¥845.59 Million | CN¥267.58 Million | ▼ -16.8 pp |
| 2010 | 71.9% | CN¥789.08 Million | CN¥1.10 Billion | CN¥962.17 Million | CN¥173.09 Million | ▼ -12.6 pp |
| 2009 | 84.5% | CN¥782.80 Million | CN¥926.88 Million | CN¥903.18 Million | CN¥120.38 Million | ▲ +72.6 pp |
| 2008 | 11.9% | CN¥14.90 Million | CN¥125.51 Million | CN¥101.92 Million | CN¥87.02 Million | ▲ +23.5 pp |
| 2007 | -11.6% | CN¥-7.13 Million | CN¥61.24 Million | CN¥103.22 Million | CN¥110.35 Million | ▲ +170.2 pp |
| 2006 | -181.8% | CN¥-38.69 Million | CN¥21.28 Million | CN¥45.65 Million | CN¥84.34 Million | — |